脂肪乳治疗动物模型的异质性与偏倚:系统评价与Meta分析
该系统评价与Meta分析纳入58项动物心脏毒性模型研究,评估静脉脂肪乳治疗的死亡率效应。脂肪乳降低全模型死亡几率(OR 0.26,95%CI 0.16-0.44,p<0.00001)。亚组分析显示局麻药中毒(OR 0.16)与非局麻药中毒(OR 0.43)均获益。异质性主要来源于动物模型种类,猪模型仅在局麻药中毒中获益(OR 0.28),非猪模型跨所有毒物均获益(OR 0.1)。作者认为异质性源于动物模型选择,猪可能因对脂肪乳的类过敏反应影响其模型价值。
要点
- 全动物模型汇总:脂肪乳降低死亡几率OR 0.26(95%CI 0.16-0.44,p<0.00001,n=60)。
- 局麻药中毒模型:脂肪乳降低死亡几率OR 0.16(95%CI 0.1-0.33)。
- 非局麻药中毒模型:脂肪乳降低死亡几率OR 0.43(95%CI 0.22-0.83)。
- 猪模型仅在局麻药中毒中获益(OR 0.28,95%CI 0.11-0.7,p=0.0033),非猪模型跨所有毒物均获益(OR 0.1,95%CI 0.06-0.16,p<0.00001)。
- 异质性主要来源于动物模型种类(Cochran's Q 132,df=59,p<0.01,I²=0.55),按猪与非猪亚组独立分析后异质性消失(I²≤0.12)。
适用人群与场景
- 动物模型(猪、大鼠、兔、狗)的心脏毒性模型,涵盖局麻药中毒与非局麻药中毒。
研究设计与关键结果
- 系统评价与Meta分析,筛选2784篇文献,最终纳入58项符合标准的研究。
- 脂肪乳治疗降低全模型死亡几率:OR 0.26(95%CI 0.16-0.44,Z=-5.21,p<0.00001,Cohen's d=0.72,n=60)。
- 局麻药中毒模型死亡几率降低:OR 0.16(95%CI 0.1-0.33)。
- 非局麻药中毒模型死亡几率降低:OR 0.43(95%CI 0.22-0.83)。
- 异质性检验:Cochran's Q 132(df=59,p<0.01),I²=0.55,主要来源于动物模型种类;按猪与非猪亚组独立分析后异质性消失(I²≤0.12)。
- 猪模型仅在局麻药中毒中获益:OR 0.28(95%CI 0.11-0.7,p=0.0033);非猪模型跨所有毒物均获益:OR 0.1(95%CI 0.06-0.16,p<0.00001)。
- Egger检验及漏斗图分析发现偏倚风险,存在离群值。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(动物模型研究)。
- 异质性主要来源于动物模型种类(Cochran's Q 132,df=59,p<0.01,I²=0.55),按猪与非猪亚组独立分析后异质性消失(I²≤0.12)。
- Egger检验及漏斗图分析发现偏倚风险,存在离群值。
- 局限:猪可能因对脂肪乳的类过敏反应影响其作为模型系统的价值;异质性可能源于脂肪乳剂量、实验设计或猪的类过敏反应。
对床旁实践的改变
- 作者认为,离群值分析强调在心脏骤停情况下需要适当的脂肪乳剂量以及气道管理和胸外按压。
- 猪模型仅在局麻药中毒中显示脂肪乳获益,可能因脂肪乳剂量、实验设计或猪对脂肪乳的类过敏反应,提示猪模型用于非局麻药中毒研究时需谨慎解读。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Clinicians utilize lipid emulsion to treat local anesthetic toxicity and non-local anesthetic toxicities, a practice supported by animal experimentation and clinical experience. Prior meta-analysis confirmed a mortality benefit of lipid emulsion in animal models of local anesthetic toxicity but the benefit of lipid emulsion in models of non-local anesthetic toxicity remains unanswered. Further, swine suffer an anaphylactoid reaction from lipid emulsions calling into question their role as a model system to study lipid, so we examined swine and non-swine dependent outcomes in models of intravenous lipid emulsion.
METHODS: We conducted a systematic review and meta-analysis examining the use of lipid emulsion therapy in animal models of cardiac toxicity. We quantified mortality using a random-effects odds-ratio method. Secondary outcomes included survival in the following subgroups: local-anesthetic systemic toxicity, non-local anesthetic toxicity, swine-based models, and non-swine models (e.g., rat, rabbit and dog). We assessed for heterogeneity with Cochran's Q and I2. We examined bias with Egger's test & funnel plot analysis.
RESULTS: Of 2784 references screened, 58 met criteria for inclusion. Treatment with lipid emulsion reduced chance of death in all models of toxicity with an odds ratio of death of 0.26 (95% CI 0.16-0.44, Z-5.21, p < 0.00001, Cohen's-d = 0.72, n = 60). Secondary outcomes confirmed a reduced chance of death in models of local anesthetic toxicity (OR 0.16 {95% CI 0.1-0.33}) and non-local anesthetic toxicity (OR 0.43 {95% CI 0.22-0.83}). Heterogeneity (Cochran's Q 132 {df = 59, p < 0.01}, I 2 = 0.55) arose primarily from animal-model and disappeared (I 2 < = 0.12) when we analyzed swine and non-swine subgroups independently. Swine only benefited in models of local anesthetic toxicity (OR 0.28 {95% CI 0.11-0.7}, p = 0.0033) whereas non-swine models experienced a homogeneous benefit across all toxins (OR 0.1 {95% CI 0.06-0.16}, p < 0.00001). Egger's test identified risk of bias with outliers on funnel plot analysis.
DISCUSSION: Lipid emulsion therapy reduces mortality in animal models of toxicity. Heterogeneity arises from the animal-model used. Swine only benefit in models of local anesthetic toxicity, potentially due to lipid dose, experimental design or swine's anaphylactoid reaction to lipid. Outlier analysis reinforced the need for appropriate dosing of lipid emulsion along with airway management and chest compressions in the setting of cardiac arrest.
参考来源
- Fettiplace MR, Pichurko AB. Heterogeneity and bias in animal models of lipid emulsion therapy: a systematic review and meta-analysis. Clin Toxicol (Phila). 2020. PMID: 33025830. doi:10.1080/15563650.2020.1814316
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。